Medicare Advantage plans improperly denying claims

Medicare Advantage plans—which cover about one-third of all Medicare beneficiaries—are improperly denying medical claims to patients and physicians, according to The New York Times. MA plans are incentivized to deny claims to boost profits, the report alleges.

The NY Times article builds off the report from the HHS Office of Inspector General published at the end of September that revealed as much as 75 percent of claims denials are overturned when appealed.

The report comes as Medicare Advantage plans are expanding supplemental benefits in attempts to lure older Americans to enroll. Experts anticipate that MA plan enrollment will grow quickly over the next few years.

MA plans are required to provide at least the same benefits as traditional Medicare and are contracted with private healthcare companies. MA plans can save money by keeping patients healthy and reducing utilization of higher-cost settings, but they can also save money by denying care claims. CMS has stated it has not tried to steer beneficiaries away from traditional Medicare to the MA plans.

The practice of improperly denying claims can put patients at risk, as the beneficiary may go without the service, according to the NY Times.

Read the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”